Transformed mucosa-associated lymphoid tissue lymphomas: A single institution retrospective study including polymerase chain reaction-based clonality analysis.


Journal

British journal of haematology
ISSN: 1365-2141
Titre abrégé: Br J Haematol
Pays: England
ID NLM: 0372544

Informations de publication

Date de publication:
08 2019
Historique:
received: 25 12 2018
accepted: 27 02 2019
pubmed: 28 5 2019
medline: 8 7 2020
entrez: 25 5 2019
Statut: ppublish

Résumé

Given the lack of consistent data regarding the clinico-pathological features and clonal lymphomagenesis of patients with mucosa-associated lymphoid tissue (MALT) lymphoma and histological transformation (HT), we have systematically analysed 379 patients (32% gastric, 68% extra-gastric; median follow-up 52 months) diagnosed with HT at the Medical University Vienna 1999-2017, and reassessed tissues of identified patients by polymerase chain reaction (PCR)-based clonality analysis. HT was documented in 12/379 patients (3·2%) and occurred at a median time of 22 months (range; 6-202 months) after diagnosis of MALT lymphoma. By PCR-based clonality analysis, we detected a clear-cut clonal relationship of MALT lymphoma and diffuse large B-cell lymphoma (DLBCL) in 8 of 11 analysed cases proving that the large majority of DLBCL following MALT lymphoma are clonally-related and constitute a real transformation. Interestingly, HT occurred within the first 2·5 years after diagnosis in patients with clonal relationship, whereas time to aggressive lymphoma was longer in patients identified as clonally-unrelated (most likely secondary) lymphoma (82-202 months), suggesting that HT is an early event in this disease. Survival of patients with HT was poor with 6/12 dying at 1·5-33 months after HT, however, patients with localized gastric transformation had a superior outcome with only 1/6 dying due to progression of lymphoma.

Identifiants

pubmed: 31124124
doi: 10.1111/bjh.15953
pmc: PMC6771836
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

448-459

Informations de copyright

© 2019 The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd.

Références

Oncologist. 2015 Aug;20(8):915-25
pubmed: 26156327
Blood. 2017 Sep 21;130(12):1409-1417
pubmed: 28720586
Blood. 2001 Jul 1;98(1):238-40
pubmed: 11418487
Int J Cancer. 2013 Feb 1;132(3):E116-27
pubmed: 22890838
Am J Pathol. 1990 May;136(5):1153-64
pubmed: 2349966
Genes Chromosomes Cancer. 2001 Aug;31(4):316-25
pubmed: 11433522
CA Cancer J Clin. 2016 Mar-Apr;66(2):153-71
pubmed: 26773441
J Clin Pathol. 2000 Mar;53(3):187-90
pubmed: 10823136
Gut Liver. 2018 May 15;12(3):278-287
pubmed: 29409307
Br J Haematol. 2016 Sep;174(6):923-31
pubmed: 27460179
J Clin Oncol. 2007 Jun 10;25(17):2426-33
pubmed: 17485708
J Clin Oncol. 2011 May 10;29(14):1827-34
pubmed: 21483014
Am J Clin Pathol. 2013 Jul;140(1):114-26
pubmed: 23765542
J Clin Pathol. 2007 Apr;60(4):361-72
pubmed: 16950858
J Clin Oncol. 2006 Jul 1;24(19):3136-41
pubmed: 16769982
F1000Res. 2018 Mar 28;7:406
pubmed: 29657712
Leukemia. 2003 Dec;17(12):2257-317
pubmed: 14671650
Blood. 1995 Dec 15;86(12):4587-93
pubmed: 8541549
Blood. 2009 Apr 9;113(15):3553-7
pubmed: 19202129
Ann Hematol. 2009 May;88(5):417-24
pubmed: 18777110
Blood. 2003 Apr 1;101(7):2489-95
pubmed: 12456507
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
Ann Oncol. 2014 Jan;25(1):210-5
pubmed: 24356632
Sci Rep. 2017 Jul 20;7(1):5963
pubmed: 28729720
Gastroenterology. 1997 Jun;112(6):1871-5
pubmed: 9178679
Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10209-13
pubmed: 10954754
Ann Oncol. 2015 Nov;26(11):2329-35
pubmed: 26400898
Br J Haematol. 2013 Jan;160(1):47-52
pubmed: 23043300
J Clin Oncol. 2017 Jun 10;35(17):1905-1912
pubmed: 28355112
Immunol Rev. 1998 Apr;162:261-80
pubmed: 9602370
Blood. 2017 Oct 12;130(15):1772-1774
pubmed: 28801448
Leukemia. 2004 Jun;18(6):1102-7
pubmed: 15085149
Cancer. 2013 Feb 1;119(3):629-38
pubmed: 22893605
Leukemia. 1996 Jul;10(7):1190-7
pubmed: 8684001
Gastroenterol Res Pract. 2015;2015:102656
pubmed: 25922601
Ann Oncol. 2017 May 1;28(5):1064-1069
pubmed: 28327924
Curr Opin Oncol. 2013 Sep;25(5):470-9
pubmed: 23942292

Auteurs

Barbara Kiesewetter (B)

Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria.

Wolfgang Lamm (W)

Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria.

Werner Dolak (W)

Department of Medicine III, Clinical Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria.

Julius Lukas (J)

Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria.

Marius E Mayerhoefer (ME)

Division of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.

Michael Weber (M)

Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.

Ana-Iris Schiefer (AI)

Department of Pathology, Medical University of Vienna, Vienna, Austria.

Christoph Kornauth (C)

Department of Pathology, Medical University of Vienna, Vienna, Austria.

Günther Bayer (G)

Department of Pathology, Medical University of Vienna, Vienna, Austria.

Ingrid Simonitsch-Klupp (I)

Department of Pathology, Medical University of Vienna, Vienna, Austria.

Markus Raderer (M)

Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH